Hartmann + Glucose Viaflo

Hartmann + Glucose Viaflo is an intravenous solution containing potassium chloride, sodium chloride, calcium chloride dihydrate, glucose, and sodium lactate. The product’s strength is not specified, and it is supplied as a sterile liquid for infusion. Designed for fluid and electrolyte replacement, the formulation provides essential ions and glucose to support extracellular volume and metabolic needs during treatment in hospital and recovery.

Hartmann + Glucose Viaflo is indicated for clinical situations that require rapid restoration of intravascular volume and electrolyte balance.

- Fluid replacement in patients with hypovolemia or dehydration. - Electrolyte replenishment after significant fluid loss (e.g., burns, diarrhea, vomiting). - Support of postoperative patients to maintain circulating volume. - Management of patients receiving parenteral nutrition who need additional glucose and electrolytes. - Treatment of metabolic acidosis when combined with appropriate clinical measures.

Adverse reactions to Hartmann + Glucose Viaflo are generally infrequent, but they can occur with any intravenous therapy.

Common: - Mild local irritation at the infusion site. - Transient nausea or vomiting. - Slight increase in serum potassium or sodium levels. - Temporary hyperglycemia in susceptible individuals.

Serious: - Severe electrolyte imbalance (hyperkalemia, hypernatremia) leading to cardiac arrhythmia. - Anaphylactic or severe allergic reaction. - Fluid overload causing pulmonary edema.

Clinicians should evaluate patient-specific factors before administering Hartmann + Glucose Viaflo to minimize risks.

- Assess baseline electrolyte and glucose levels; adjust infusion rate accordingly. - Use caution in patients with renal or cardiac impairment due to risk of fluid overload. - Avoid rapid infusion in neonates or patients with compromised vascular integrity. - Monitor for signs of hyperkalemia, especially in those receiving potassium‑sparing medications. - Do not administer to patients with known hypersensitivity to any component of the solution. - Consider alternative fluids for patients with severe metabolic acidosis not corrected by lactate.

Hartmann + Glucose Viaflo may interact with other medications that affect electrolyte balance, glucose metabolism, or fluid status.

Avoid: - Concurrent high‑dose potassium supplements or potassium‑sparing diuretics, which can precipitate hyperkalemia. - Large volumes of other sodium‑rich IV fluids that may cause hypernatremia. - Intravenous insulin administered without glucose monitoring, increasing risk of hypoglycemia.

Use with caution: - Loop or thiazide diuretics, requiring close monitoring of electrolyte shifts. - Calcium channel blockers, as rapid changes in calcium levels may affect cardiac conduction. - Blood transfusions, because combined fluid loads can lead to volume overload. - Medications that alter lactate metabolism, such as metformin, necessitating careful acid‑base assessment.